Scholar Rock

$57.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$4.37 (+8.23%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Scholar Rock and other stocks, options, and ETFs commission-free!

About SRRK

Scholar Rock Holding Corporation Common Stock, also called Scholar Rock, is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA. The listed name for SRRK is Scholar Rock Holding Corporation Common Stock.

CEO

Stuart Anthony Kingsley

Employees

Headquarters

Cambridge, Massachusetts

Founded

2012

Market Cap

1.88B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

228.47K

High Today

$57.50

Low Today

$53.10

Open Price

$53.28

Volume

159.28K

52 Week High

$61.10

52 Week Low

$9.23

Collections

SRRK Earnings

-$0.79

-$0.53

-$0.26

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, Pre-Market